# MEMANTINE HYDROCHLORIDE — FDA application ANDA205825

Informational only - not investment advice.

Application ANDA205825 · type ANDA · FDA status: approved · original approval 2016-10-12

Listed sponsor: AMNEAL PHARMS · [AMRX company profile](/company/AMRX/) · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

## FDA application facts

| Product | FDA-listed trade name | Active ingredient | Dosage form | Route | Strength | Marketing status | TE code | RLD |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | ORAL | 7MG | Prescription | AB | No |
| 002 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | ORAL | 14MG | Prescription | AB | No |
| 003 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | ORAL | 21MG | Prescription | AB | No |
| 004 | MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | ORAL | 28MG | Prescription | AB | No |

## Orange Book patent and exclusivity listings

No Orange Book patent or exclusivity listings joined to this application.

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

## Compound cross-links

- MEMANTINE HYDROCHLORIDE · UNII JY0WD0UA60 · [lmmol compound LDDHMLJTFXJGPI-UHFFFAOYSA-N](https://lmmol.com/compound/LDDHMLJTFXJGPI-UHFFFAOYSA-N)

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

## Related pages

- [Sponsor company](/company/AMRX/)
- [FDA-approved application index](/drug/)

Sources: https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files · https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files · https://api.fda.gov/drug/drugsfda.json?search=application_number:ANDA205825. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.